Hodgkin's Disease Clinical Trials Hodgkin's Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
Conditions:   Hodgkin Lymphoma;   Refractory Hodgkin Lymphoma;   Relapsed Hodgkin's Disease, Adult Intervention:   Drug: Brentuximab Vedotin 50 MG [Adcetris] Sponsors:   Hospital Regional de Alta Especialidad del Bajio;   Universidad de Guanajuato Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2022 Category: Research Source Type: clinical trials

A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Conditions:   Lymphoma, Mantle-Cell;   Lymphoma;   Lymphoproliferative Disorders;   Lymphatic Diseases;   Immunoproliferative Disorders;   Immune System Diseases;   Lymphoma, Non-Hodgkin;   Lymphoma, B-Cell Interventions:   Drug: Zilovertamab;   Drug: Ibrutinib;   Drug: Placebo Sponsors:   Oncternal Therapeutics, Inc;   Pharmacyclics LLC. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2022 Category: Research Source Type: clinical trials